Mogy Joel R Investment Counsel Inc. increased its stake in shares of Stryker Corporation (NYSE:SYK) by 0.4% in the fourth quarter, HoldingsChannel.com reports. The firm owned 86,243 shares of the medical technology company’s stock after buying an additional 385 shares during the period. Stryker accounts for approximately 2.1% of Mogy Joel R Investment Counsel Inc.’s portfolio, making the stock its 19th largest holding. Mogy Joel R Investment Counsel Inc.’s holdings in Stryker were worth $13,354,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of the stock. WFG Advisors LP boosted its position in shares of Stryker by 1.6% during the 2nd quarter. WFG Advisors LP now owns 2,041 shares of the medical technology company’s stock worth $283,000 after purchasing an additional 32 shares during the period. Advisory Services Network LLC boosted its position in shares of Stryker by 1.8% during the 2nd quarter. Advisory Services Network LLC now owns 3,398 shares of the medical technology company’s stock worth $472,000 after purchasing an additional 59 shares during the period. Linscomb & Williams Inc. boosted its position in shares of Stryker by 1.2% during the 2nd quarter. Linscomb & Williams Inc. now owns 10,486 shares of the medical technology company’s stock worth $1,455,000 after purchasing an additional 121 shares during the period. Cornerstone Capital Management Holdings LLC. boosted its position in shares of Stryker by 0.3% during the 2nd quarter. Cornerstone Capital Management Holdings LLC. now owns 53,572 shares of the medical technology company’s stock worth $7,434,000 after purchasing an additional 135 shares during the period. Finally, Optimum Investment Advisors boosted its position in shares of Stryker by 4.5% during the 2nd quarter. Optimum Investment Advisors now owns 3,475 shares of the medical technology company’s stock worth $482,000 after purchasing an additional 150 shares during the period. 74.85% of the stock is owned by hedge funds and other institutional investors.

Shares of Stryker Corporation (NYSE:SYK) opened at $151.22 on Friday. Stryker Corporation has a fifty-two week low of $122.28 and a fifty-two week high of $170.00. The firm has a market cap of $56,653.36, a price-to-earnings ratio of 23.30, a PEG ratio of 2.17 and a beta of 0.70. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.29 and a quick ratio of 1.59.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.95 by $0.01. Stryker had a net margin of 8.20% and a return on equity of 24.55%. The business had revenue of $3.47 billion for the quarter, compared to analyst estimates of $3.42 billion. During the same period last year, the business earned $1.78 EPS. The company’s revenue was up 9.9% on a year-over-year basis. sell-side analysts anticipate that Stryker Corporation will post 7.12 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be given a $0.47 dividend. This represents a $1.88 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date is Wednesday, March 28th. Stryker’s dividend payout ratio (DPR) is 70.15%.

A number of equities research analysts have issued reports on SYK shares. SunTrust Banks reiterated a “buy” rating and set a $179.00 target price (up from $161.00) on shares of Stryker in a report on Friday, January 26th. Cantor Fitzgerald reiterated a “hold” rating and set a $163.00 target price on shares of Stryker in a report on Tuesday, January 30th. Needham & Company LLC reiterated a “hold” rating on shares of Stryker in a report on Wednesday, January 31st. Leerink Swann increased their target price on shares of Stryker from $177.00 to $184.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Finally, Oppenheimer reiterated a “hold” rating and set a $165.00 target price on shares of Stryker in a report on Thursday, February 1st. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have issued a buy rating to the company. Stryker has a consensus rating of “Hold” and an average target price of $162.50.

In related news, VP William E. Berry, Jr. sold 1,306 shares of the stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $164.42, for a total value of $214,732.52. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Graham A. Mclean sold 2,984 shares of the stock in a transaction on Monday, February 5th. The shares were sold at an average price of $160.53, for a total transaction of $479,021.52. Following the completion of the transaction, the insider now directly owns 9,100 shares in the company, valued at $1,460,823. The disclosure for this sale can be found here. Insiders sold a total of 16,840 shares of company stock worth $2,749,989 over the last ninety days. Insiders own 7.40% of the company’s stock.

WARNING: This piece was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://theolympiareport.com/2018/02/11/stryker-corporation-syk-shares-bought-by-mogy-joel-r-investment-counsel-inc.html.

Stryker Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.